Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.8%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
Drug repurposing (DR) is a strategy to develop novel drugs from pre-approved drugs.
APA
Ishaq M, Zafar E, et al. (2026). Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.. Naunyn-Schmiedeberg's archives of pharmacology, 399(1), 47-62. https://doi.org/10.1007/s00210-025-04508-x
MLA
Ishaq M, et al.. "Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.." Naunyn-Schmiedeberg's archives of pharmacology, vol. 399, no. 1, 2026, pp. 47-62.
PMID
40788483 ↗
Abstract 한글 요약
Drug repurposing (DR) is a strategy to develop novel drugs from pre-approved drugs. To overcome the limitations of conventional drug development pathways, DR is a novel method that is cost-effective, with minimal side effects, and less time-consuming. Contrary to de novo drug discovery, DR eliminates the need for FDA approval. Fluoroquinolones (FQs) are potentially antibiotics, but recently, it has been discovered that FQs are a potential "treasure trove" to circumvent cancer drug resistance. Various in vitro studies on FQs showed their anticancer functionality against various cancer cell lines. Moreover, FQs are found to enhance the therapeutic efficacy of various clinical drugs by acting synergistically or additively in combination therapy. FQs such as ciprofloxacin, moxifloxacin, and levofloxacin are found to enhance the anti-tumor effect of a wide range of FDA-approved chemotherapeutics through multiple mechanisms including cell cycle arrest, apoptosis induction, anti-proliferation, and modulation of EMT. This review will comprehensively focus on the chemosensitization mechanism and cellular targets of FQs. This study provides a scientific basis to explore FQs as potential chemotherapeutic agents for combinational therapy to tackle the current scenario of drug resistance.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.